PEA15 anticorps (C-Term)
Aperçu rapide pour PEA15 anticorps (C-Term) (ABIN929087)
Antigène
Voir toutes PEA15 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Purified
-
Immunogène
- PEA15 antibody was raised in rabbit using the C terminal of PEA15 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PEA15 Blocking Peptide, (ABIN937632), is also available for use as a blocking control in assays to test for specificity of this PEA15 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PEA15 (phosphoprotein Enriched in Astrocytes 15 (PEA15))
-
Autre désignation
- PEA15
-
Sujet
- PEA15 is a death effector domain (DED)-containing protein predominantly expressed in the central nervous system, particularly in astrocytes. Synonyms: Polyclonal PEA15 antibody, Anti-PEA15 antibody, phosphoprotein enriched in astrocytes 15 antibody, HMAT1 antibody, HUMMAT1H antibody, MAT1 antibody, MAT1H antibody, PEA-15 antibody, PED antibody.
Antigène
-